United States - English - NLM (National Library of Medicine)

avion pharmaceuticals, llc - ferrous bisglycinate (unii: sfw1d987qv) (ferrous cation - unii:gw89581owr), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (biotin - unii:6so6u10h04), cupric oxide (unii: v1 - ferrous cation 36.7 mg - indications: feriva fa ® is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency. contraindications: feriva fa ® is contraindicated in patients with a known hypersensitivity to any of the ingredients. hemochromatosis and hemosiderosis are contraindicated to iron therapy. pediatric use: safety and effectiveness have not been studied in pediatric patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

carotino (australia) pty ltd - folic acid, quantity: 0.3 mg; ferrous sulfate, quantity: 270 mg (equivalent: iron, qty 87.4 mg) - capsule, modified release - excipient ingredients: sunset yellow fcf; glyceryl monostearate; maize starch; quinoline yellow; purified talc; calcium sulfate dihydrate; hydrochloric acid; erythrosine; sucrose; gelatin; povidone; white beeswax; titanium dioxide; brilliant blue fcf - for the prevention and treatment of iron and folate deficiency,supplies iron to the body which may help in the production of energy,can help relieve fatigue associated with iron deficiency

Malta - English - Medicines Authority

bial - portela & c s.a. À av. da siderurgia nacional, 4745-457 s. mamede do coronado, portugal - folic acid, iron - film-coated tablet - folic acid 1 mg iron 90 mg - antianemic preparations

Malta - English - Medicines Authority

wallace manufacturing chemists limited 51-53 stert street, abingdon, ox14 3jf, united kingdom - folic acid, ascorbic acid, ferrous sulfate, exsiccated, nicotinamide, thiamine hydrochloride, riboflavin - soft capsule - folic acid 1.7 mg ascorbic acid 15 mg ferrous sulfate exsiccated 195 mg nicotinamide 10 mg thiamine hydrochloride 1 mg riboflavin 2 mg - antianemic preparations

Australia - English - Department of Health (Therapeutic Goods Administration)

star combo australia pty ltd - ascorbic acid,calcium hydrogen phosphate dihydrate,cyanocobalamin,ferrous fumarate,folic acid,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine -

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 151 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions). soybean oil, lecithin, di calcium phosphate anhydrous, beeswax yellow, hydrogenated soybean oil.

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions).

United States - English - NLM (National Library of Medicine)

trigen laboratories, llc - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), calcium pantothenate (unii: 568et80c3d) (calcium cation - unii - ferrous cation 130 mg - folivane™-ob is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemia. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

United States - English - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc. - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), calcium sulfate (unii: wat0ddb505) (calcium cation - unii:2m83c4r6zb), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thia - folic acid 1 mg - niva-plus™ is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation. this product is contraindicated in patients with known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

jaymac pharmaceuticals llc - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (iron - unii:e1uol152h7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine mononitrate (unii: 8k0i04919x) (thiamine - unii:x66nso3n35), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochlorid - folic acid 1 mg - viva® ct prenatal chewable is indicated for the distinct nutritional requirements of individuals in need of prenatal/postnatal dietary supplementation as determined by a licensed medical practitioner. this product can be used fordietary management prior to conception. viva® ct prenatal chewable should be administered under the supervision of a licensed medical practitioner. viva® ct prenatal chewable is contraindicated in individuals with a known hypersensitivity to any of the ingredients.